Literature DB >> 26676659

Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

Mark A Yorek1.   

Abstract

This article reviews the impact of diabetes and its treatment on vascular function with a focus on the reactivity of epineurial arterioles, blood vessels that provide circulation to the sciatic nerve. Another focus is the relationship between the dysregulation of neurovascular function and diabetic peripheral neuropathy. Diabetic peripheral neuropathy is a debilitating disorder that occurs in more than 50 percent of patients with diabetes. The etiology involves metabolic, vascular, and immunologic pathways besides neurohormonal growth factor deficiency and extracellular matrix remodeling. In the light of this complex etiology, an effective treatment for diabetic peripheral neuropathy has not yet been identified. Current opinion postulates that any effective treatment for diabetic peripheral neuropathy will require a combination of life style and therapeutic interventions. However, a more comprehensive understanding of the factors contributing to neurovascular and neural dysfunction in diabetes is needed before such a treatment strategy can be developed. After reading this review, the reader should have gained insight into the complex regulation of vascular function and blood flow to the sciatic nerve, and the impact of diabetes on numerous elements of vascular reactivity of epineurial arterioles of the sciatic nerve.

Entities:  

Mesh:

Year:  2015        PMID: 26676659      PMCID: PMC5397981          DOI: 10.1900/RDS.2015.12.13

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  167 in total

Review 1.  Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.

Authors:  P Sytze van Dam
Journal:  Diabetes Metab Res Rev       Date:  2002 May-Jun       Impact factor: 4.876

Review 2.  Vascular and cardiac benefits of angiotensin receptor blockers.

Authors:  Ernesto L Schiffrin
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

3.  Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.

Authors:  M Julia Brosnan; Carlene A Hamilton; Delyth Graham; Craig A Lygate; Emma Jardine; Anna F Dominiczak
Journal:  J Hypertens       Date:  2002-02       Impact factor: 4.844

4.  Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats.

Authors:  M A Cotter; N E Cameron
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1997-05       Impact factor: 4.006

Review 5.  Experimental diabetic neuropathy: an update.

Authors:  A A Sima; K Sugimoto
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

6.  The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

Authors:  Pal Pacher; Lucas Liaudet; Francisco Garcia Soriano; Jon G Mabley; Eva Szabó; Csaba Szabó
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

7.  Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

Authors:  K Terata; L J Coppey; E P Davidson; J A Dunlap; D D Gutterman; M A Yorek
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

8.  Neutral endopeptidase expression in mesangial cells.

Authors:  Fabiana Ebihara; Giovana Seno Di Marco; Maria Aparecida Juliano; Dulce Elena Casarini
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2003-12       Impact factor: 1.636

Review 9.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

10.  Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Authors:  C L Oltman; E P Davidson; L J Coppey; T L Kleinschmidt; M A Yorek
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

View more
  12 in total

1.  miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice.

Authors:  Lei Wang; Michael Chopp; XueRong Lu; Alexandra Szalad; LongFei Jia; Xian Shuang Liu; Kuan-Han Wu; Mei Lu; Zheng Gang Zhang
Journal:  Brain Res       Date:  2018-11-27       Impact factor: 3.252

Review 2.  Zebrafish is a central model to dissect the peripheral neuropathy.

Authors:  So Yeon Won; Byung-Ok Choi; Ki Wha Chung; Ji Eun Lee
Journal:  Genes Genomics       Date:  2019-06-10       Impact factor: 1.839

3.  Painful diabetic neuropathy leads to functional CaV3.2 expression and spontaneous activity in skin nociceptors of mice.

Authors:  Tal Hoffmann; Katrin Kistner; Sonja L J Joksimovic; Slobodan M Todorovic; Peter W Reeh; Susanne K Sauer
Journal:  Exp Neurol       Date:  2021-08-25       Impact factor: 5.330

4.  Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.

Authors:  Lei Wang; Michael Chopp; Alexandra Szalad; XueRong Lu; LongFei Jia; Mei Lu; Rui Lan Zhang; Zheng Gang Zhang
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

5.  Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.

Authors:  Eric P Davidson; Lawrence J Coppey; Hanna Shevalye; Alexander Obrosov; Mark A Yorek
Journal:  J Diabetes Res       Date:  2018-07-02       Impact factor: 4.011

Review 6.  Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications.

Authors:  Masaki Kobayashi; Douglas W Zochodne
Journal:  J Diabetes Investig       Date:  2018-04-25       Impact factor: 4.232

Review 7.  Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis.

Authors:  De-Qi Jiang; Lan-Cheng Xu; Li-Lin Jiang; Ming-Xing Li; Yong Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  Hypertension Contributes to Neuropathy in Patients With Type 1 Diabetes.

Authors:  Georgios Ponirakis; Ioannis N Petropoulos; Uazman Alam; Maryam Ferdousi; Omar Asghar; Andrew Marshall; Shazli Azmi; Maria Jeziorska; Ziyad R Mahfoud; Andrew J M Boulton; Nathan Efron; Hitoshi Nukada; Rayaz A Malik
Journal:  Am J Hypertens       Date:  2019-07-17       Impact factor: 2.689

9.  Effectiveness of acupuncture combined mecobalamin in the treatment of elderly diabetic peripheral neuropathy: A protocol of systematic review and meta-analysis.

Authors:  Yu-Hong Duan; Ai-Xia Liu; Hong-Xia Su; Ji-Hong Lv; Xue-Ying Gong; Li Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

10.  TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy.

Authors:  Haruka Hiyama; Yuichi Yano; Kanako So; Satoshi Imai; Kazuki Nagayasu; Hisashi Shirakawa; Takayuki Nakagawa; Shuji Kaneko
Journal:  Mol Pain       Date:  2018-07-03       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.